Pito Chickering
Stock Analyst at Deutsche Bank
(4.44)
# 1,164
Out of 4,988 analysts
379
Total ratings
60%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Rated: Hold | $85 → $92 | $92.13 | -0.14% | 22 | Sep 3, 2026 | |
| MMED MiniMed Group | Rated: Buy | $20 → $25 | $21.79 | +14.73% | 2 | Sep 2, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $31.64 | +16.94% | 4 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $107 → $98 | $95.36 | +2.77% | 18 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $183.86 | +44.13% | 22 | Aug 5, 2026 | |
| MD Pediatrix Medical Group | Rated: Hold | $19 → $25 | $25.93 | -3.59% | 20 | Aug 5, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $60 → $70 | $56.78 | +23.28% | 8 | Aug 3, 2026 | |
| BAX Baxter International | Reiterated: Hold | $20 → $27 | $22.80 | +18.42% | 16 | Jul 31, 2026 | |
| LH Labcorp Holdings | Rated: Hold | $248 → $306 | $320.71 | -4.59% | 14 | Jul 31, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $108 → $60 | $43.34 | +38.44% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $24 | $24.30 | -1.23% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $441 → $476 | $427.71 | +11.29% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $28.33 | +12.95% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $402 → $315 | $275.12 | +14.50% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $16 | $16.85 | -5.04% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $5.71 | +66.37% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $11.08 | +98.56% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $12 | $13.67 | n/a | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $94 | $88.26 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 → $178 | $246.45 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.3592 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 → $18 | $0.015 | n/a | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $241 | $317.60 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $176.69 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $95 | $121.75 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $261.99 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 | $27.29 | n/a | 1 | Apr 19, 2021 |
Medtronic
Sep 3, 2026
Rated: Hold
Price Target: $85 → $92
Current: $92.13
Upside: -0.14%
MiniMed Group
Sep 2, 2026
Rated: Buy
Price Target: $20 → $25
Current: $21.79
Upside: +14.73%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $31.64
Upside: +16.94%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $107 → $98
Current: $95.36
Upside: +2.77%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $183.86
Upside: +44.13%
Pediatrix Medical Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $25.93
Upside: -3.59%
BrightSpring Health Services
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $56.78
Upside: +23.28%
Baxter International
Jul 31, 2026
Reiterated: Hold
Price Target: $20 → $27
Current: $22.80
Upside: +18.42%
Labcorp Holdings
Jul 31, 2026
Rated: Hold
Price Target: $248 → $306
Current: $320.71
Upside: -4.59%
Boston Scientific
Jul 30, 2026
Reiterated: Buy
Price Target: $108 → $60
Current: $43.34
Upside: +38.44%
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $24.30
Upside: -1.23%
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $427.71
Upside: +11.29%
May 1, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $28.33
Upside: +12.95%
May 1, 2026
Reiterated: Hold
Price Target: $402 → $315
Current: $275.12
Upside: +14.50%
Apr 30, 2026
Reiterated: Hold
Price Target: $18 → $16
Current: $16.85
Upside: -5.04%
Feb 25, 2026
Reiterated: Hold
Price Target: $9.5
Current: $5.71
Upside: +66.37%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $11.08
Upside: +98.56%
Sep 15, 2025
Reiterated: Buy
Price Target: $7 → $12
Current: $13.67
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: $85 → $94
Current: $88.26
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: $136 → $178
Current: $246.45
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.3592
Upside: n/a
Nov 8, 2024
Rated: Hold
Price Target: $26 → $18
Current: $0.015
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $205 → $241
Current: $317.60
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $176.69
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $83 → $95
Current: $121.75
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $261.99
Upside: n/a
Apr 19, 2021
Reiterated: Hold
Price Target: $62
Current: $27.29
Upside: n/a